目前沒有任何討論
AIMD Ainos
1.9
0.03
(-1.55%)
Ainos AIMD 生物技術:藥物製劑
1.9
0.03
(-1.55%)
單位:美金千元
| 科目 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | 2022/Q3 | 2022/Q2 | 2022/Q1 | 2021/Q4 | 2021/Q3 | 2021/Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
總資產
| 22,679 | 23,922 | 26,353 | 28,820 | 31,370 | 35,539 | 29,754 | 31,842 | 33,860 | 34,046 | 36,708 | 37,109 | 39,082 | 40,413 | 40,736 | 40,822 | 19,994 | 20,622 |
流動資產
| 1,721 | 1,734 | 3,051 | 4,338 | 5,649 | 8,472 | 1,509 | 2,473 | 3,040 | 2,140 | 3,633 | 2,846 | 3,668 | 3,699 | 3,023 | 2,218 | 885 | 869 |
現金及約當現金
| 1,128 | 1,223 | 2,628 | 3,893 | 5,157 | 8,014 | 1,031 | 1,886 | 2,371 | 1,361 | 1,146 | 1,853 | 2,417 | 1,754 | 1,871 | 1,751 | 707 | 607 |
短期投資合計
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
應收帳款淨額
| - | - | - | - | - | - | 4 | - | - | 9 | 1,611 | 202 | 400 | - | - | - | 45 | 140 |
存貨
| 167 | 160 | 142 | 144 | 161 | 166 | 170 | 168 | 217 | 528 | 572 | 595 | 698 | 671 | 338 | - | - | 0 |
其他流動資產
| 426 | 351 | 281 | 301 | 332 | 291 | 305 | 420 | 452 | 241 | 303 | 196 | 152 | 1,275 | 814 | 466 | 133 | - |
非流動資產
| 20,959 | 22,188 | 23,302 | - | - | - | - | 29,369 | 30,819 | 31,906 | 33,076 | 34,264 | 35,413 | 36,714 | 37,714 | 38,605 | 19,109 | 19,753 |
長期投資合計
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
不動產、廠房及設備
| 415 | 495 | 494 | 560 | 649 | 691 | 769 | 877 | 1,161 | 1,269 | 1,315 | 1,376 | 1,351 | 1,503 | 1,420 | 1,188 | 40 | 84 |
商譽
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
無形資產
| 20,366 | 21,506 | 22,633 | 23,748 | 24,888 | 26,028 | 27,156 | 28,283 | 29,423 | 30,564 | 31,692 | 32,807 | 33,946 | 35,086 | 36,214 | 37,329 | 19,011 | 19,669 |
遞延費用
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
其他非流動資產
| 178 | 187 | 175 | 174 | 183 | 349 | 321 | 209 | 235 | 73 | 69 | 81 | 116 | 125 | 80 | 88 | 58 | - |
總負債
| 12,634 | 12,479 | 13,231 | 13,304 | 13,348 | 14,827 | 7,076 | 7,394 | 6,179 | 3,651 | 4,370 | 2,481 | 2,656 | 34,407 | 32,654 | 30,625 | 2,857 | 2,417 |
流動負債
| 581 | 603 | 1,523 | 3,955 | 4,131 | 5,743 | 4,706 | 1,337 | 819 | 1,114 | 1,867 | 2,473 | 2,643 | 6,988 | 5,730 | 30,595 | 2,822 | 2,376 |
應付帳款
| 581 | 603 | 1,523 | 3,849 | 4,021 | 4,051 | 4,598 | 1,224 | 708 | 1,114 | 1,867 | 1,212 | 1,383 | 2,598 | 1,340 | 27,005 | 2,579 | - |
短期借款
| - | - | - | - | - | 1,586 | - | - | - | - | - | 1,261 | 1,261 | 4,390 | 4,390 | 3,590 | 185 | 1,732 |
其他流動負債
| - | - | - | 106 | 110 | 107 | 108 | 113 | 112 | - | - | - | - | - | - | - | 58 | - |
非流動負債
| 12,053 | 11,877 | 11,708 | - | - | - | - | 6,058 | 5,359 | 2,538 | 2,503 | 8 | 13 | 27,418 | 26,924 | 30 | 35 | 41 |
長期負債
| 11,000 | 11,000 | 11,000 | 9,000 | 9,000 | 9,000 | 2,370 | 5,652 | 5,000 | 2,500 | 2,500 | - | - | 27,400 | 26,900 | - | - | - |
非控制權益
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
遞延收入
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
其他非流動負債
| 1,053 | 877 | 708 | - | - | - | - | 406 | 359 | 38 | 3 | 8 | 13 | 18 | 24 | 30 | 35 | - |
股東權益
| 10,045 | 11,443 | 13,122 | 15,516 | 18,022 | 20,712 | 22,679 | 24,448 | 27,681 | 30,395 | 32,338 | 34,628 | 36,426 | 6,006 | 8,083 | 10,197 | 17,136 | 18,206 |
普通股股本
| 48 | 43 | 172 | 154 | 138 | 74 | 61 | 47 | 203 | 203 | 200 | 200 | 195 | 1,444 | 1,444 | 1,444 | 1,424 | 1,423 |
資本公債
| -63,052 | -60,120 | -56,035 | -52,749 | -48,095 | -44,396 | -41,201 | -37,886 | -31,962 | -28,986 | -26,636 | -24,116 | -21,985 | -14,163 | -12,209 | -10,109 | -8,664 | - |
保留盈餘
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7,504 |
庫藏股票
| 73,263 | 71,669 | 69,435 | 68,521 | 66,224 | 65,415 | 64,154 | 62,556 | 59,764 | 59,424 | 58,966 | 58,745 | 58,492 | 18,943 | 18,900 | 18,856 | 24,369 | - |
其他權益
| -214 | -148 | -450 | -410 | -244 | -380 | -336 | -269 | -324 | -245 | -192 | -202 | -276 | -218 | -52 | 6 | 7 | - |